Reporting of an adverse event, a product quality problem or a product use error

Please call
Dr Gabriel Cozma (Head of Pharmacovigilance Unit): +41 79 337 76 91 or
Stéphane Michaut (Pharmacovigilance Coordinator) : +41 79 779 04 33
and send a fax to +41 22 783 11 80, stating your name, address, phone number and name of the product.

OM PHARMA main contacts

PRESIDENT, GENERAL MANAGER: Christophe Ricard
Assistants: Johanna Kunzi / Ghislaine Desmeules-Rossi

INFORMATION AND COMMUNICATIONS: Philippe Meuwly

STRATEGIC PLANNING: Philippe Meuwly

CONTROLLING: Winston Kenzey

BUSINESS DEVELOPMENT : Philippe Meuwly
• Licensing-in new products : Antoine Zermatten
• Business development biological products : Philippe Meuwly
• Business development synthetic products : Margaret Bergerioux
• Licensing-out R&D products : David Limal

HUMAN RESOURCES: Christian Pruneaud

QUALITY, ENVIRONMENT, SECURITY: Philippe Jaccard

RESEARCH & DEVELOPMENT: Jacques Bauer

MEDICAL & REGULATORY / PHARMACOVIGILANCE: Gabriel Cozma

COMMERCIAL
International Operations: Reto Baumann
• Export, Western Europe and Switzerland: Myrta Keller
• Export, Eastern Europe: Myrta Keller
• Export, Latin America: Laurent Taglialatela
• Export, Middle East and Africa: Nicolas Ghosn
• Export, Far East: Nicolas Ghosn

International Marketing & Sales: Eduardo Barriga-Garcia
• Marketing & Sales Western Europe and Switzerland: Richard Damien
• Marketing & Sales Eastern Europe: Eduardo Barriga-Garcia
• Marketing & Sales Latin America: Pierre Pialoux
• Marketing & Sales Middle East and Africa: Siham Azi
• Marketing & Sales Far East: Eduardo Barriga-Garcia
• International Marketing Manager : François Boualavong

PRODUCTION: Gilbert Fumex

FINANCE: David Harar-Kenzey

ADMINISTRATION: Winston Kenzey

SUBSIDIARIES
• OM PORTUGUESA: Antonio Jordao
• OM PERU: Antonio Ciudad
• OM CENTRO AMERICA: Reto Baumann


Top of the page